The University of Cambridge is to take a leading role in a major national effort to help understand and control the new coronavirus infection (COVID-19) announced today by the Government and the UK’s Chief Scientific Adviser.
Two major research collaborations led by the University of Cambridge have been awarded almost £15 million in funding, the Minister of State for Universities and Science, Jo Johnson MP, announced today during a visit to Cambridge’s Sainsbury Laboratory.
Some people with high levels of ‘good’ high density lipoprotein cholesterol (HDL-C) are at increased risk of coronary heart disease, contrary to earlier evidence that people with more HDL-C are usually at lower heart disease risk. This finding comes from an international study involving researchers at the University of Cambridge, funded by the British Heart Foundation (BHF).
Life expectancy for people with a history of both cardiovascular disease and diabetes is substantially lower than for people with just one condition or no disease, a new study harnessing the power of ‘big data’ has concluded.
The Academy of Medical Sciences has announced the election of its new Fellows, including five Cambridge University academics.
Inflammation – the body’s response to damaging stimuli – may have a protective effect against cardiovascular disease, according to a study published today in the journal Lancet Diabetes and Endocrinology.
The University of Cambridge has received £7.9 million from the National Institute for Health Research (NIHR) to fund Blood and Transplant Research Units. Each Unit is a partnership between University researchers and NHS Blood and Transplant, and will begin in October 2015.
Fundraising is under way for a joint Cambridge University and Papworth Hospital Heart and Lung Research Institute – to sit alongside the anticipated new Papworth Hospital on the Cambridge Biomedical Campus – enabling a major expansion of cardiorespiratory research in Cambridge.
A study commencing in the same week as World Blood Donor Day will determine whether blood can be safely collected more frequently than present practice.
Population studies on a vast scale are providing the power to enable accurate risk assessment – and intervention – into cardiovascular disease.
© 2025 University of Cambridge